Insider Trading activities of Regeneron Pharmaceuticals Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Regeneron Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is REGN. The reporting company's CIK number is 872589.
The total value of stock buying since 2005 is $2,475,753,844.
The total value of stock sales since 2005 is $1,068,888,188.
The total value of stock option exercises since 2005 is $284,711,527.



Table 2. Detailed insider stock purchases, sales, and option exercises of Regeneron Pharmaceuticals Inc insiders (REGN) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-12-31 Powchik Peter (SVP Clinical Development & Reg) Option Ex 48,000 30.63 1,470,240
2013-12-24 Powchik Peter (SVP Clinical Development & Reg) Option Ex 4,705 21.25 99,981
2013-12-20 Powchik Peter (SVP Clinical Development & Reg) Sale 133 271.09 36,054
2013-12-19 Yancopoulos George (President Regeneron Laboratori) Option Ex 4,705 21.25 99,981
2013-12-18 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 4,705 21.25 99,981
2013-12-18 Terifay Robert J (SVP Commercial) Option Ex 4,705 21.25 99,981
2013-12-18 Powchik Peter (SVP Clinical Development & Reg) Sale 9,000 270.20 2,431,800
2013-12-18 Powchik Peter (SVP Clinical Development & Reg) Option Ex 295 21.25 6,268
2013-12-18 Stahl Neil (SVP Research and Development S) Option Ex 4,705 21.25 99,981
2013-12-18 Goldberg Murray A (SVP Administration & Asst Secr) Option Ex 4,705 21.25 99,981
2013-12-17 Powchik Peter (SVP Clinical Development & Reg) Sale 8 270.00 2,160
2013-12-16 Powchik Peter (SVP Clinical Development & Reg) Option Ex 30,625 87.26 2,672,429
2013-12-12 Yancopoulos George (Pres Regeneron Labs) Option Ex 9,599 260.44 2,499,963
2013-12-02 Vagelos P Roy (Chairman of the Board) Sale 95 296.11 28,130
2013-11-26 Sing George L (Director) Sale 10,000 295.00 2,950,000
2013-11-26 Sing George L (Director) Option Ex 10,000 15.01 150,100
2013-11-06 Goldstein Joseph L (Director) Sale 1,000 300.74 300,740
2013-10-02 Schleifer Leonard S (President & CEO) Sale 9,162 314.84 2,884,582
2013-10-01 Schleifer Leonard S (President & CEO) Option Ex 29,276 111.01 3,249,928
2013-09-30 Baker Charles A (Director) Sale 15,000 313.33 4,699,920
2013-09-30 Baker Charles A (Director) Option Ex 15,000 19.69 295,350
2013-09-26 Brown Michael S (Director) Sale 5,000 309.00 1,545,000
2013-09-26 Brown Michael S (Director) Option Ex 5,000 33.42 167,100
2013-09-25 Brown Michael S (Director) Sale 5,000 294.38 1,471,875
2013-09-25 Brown Michael S (Director) Option Ex 5,000 33.42 167,100
2013-09-19 Schleifer Leonard S (President & CEO) Sale 102,949 305.45 31,446,286
2013-09-19 Vagelos P Roy (Chairman of the Board) Sale 145,356 305.31 44,378,204
2013-09-18 Van Plew Daniel P (SVP & Gen Mgr IOPS) Sale 23,977 303.39 7,274,406
2013-09-18 Roberts William (VP Reg Dev & Med Safety) Sale 15,000 304.00 4,560,000
2013-09-18 Roberts William (VP Reg Dev & Med Safety) Option Ex 15,000 16.80 252,000
2013-09-18 Schleifer Leonard S (President & CEO) Option Ex 218,389 9.49 2,072,511
2013-09-18 Vagelos P Roy (Chairman of the Board) Option Ex 312,500 13.00 4,062,500
2013-09-17 Van Plew Daniel P (SVP & Gen Mgr IOPS) Option Ex 52,500 16.80 882,000
2013-09-09 Schleifer Leonard S (CEO & President) Sale 5,000 276.21 1,381,050
2013-08-23 Goldstein Joseph L (Director) Sale 1,000 238.29 238,290
2013-08-23 Ryan Arthur F (Director) Sale 10,958 238.47 2,613,154
2013-08-22 Ryan Arthur F (Director) Option Ex 30,000 33.39 1,001,640
2013-08-01 Goldberg Murray A (SVP Finance and Admin CFO and) Option Ex 5,000 16.80 84,000
2013-06-17 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 3,900 24.00 93,600
2013-06-10 Baker Charles A (Director) Sale 15,000 253.54 3,803,145
2013-06-10 Baker Charles A (Director) Option Ex 15,000 15.80 237,000
2013-05-31 Ryan Arthur F (Director) Sale 2,500 249.51 623,787
2013-05-28 Goldstein Joseph L (Director) Sale 4,000 252.20 1,008,800
2013-05-21 Goldberg Murray A (SVP Finance and Admin CFO and) Sale 66,835 260.03 17,379,171
2013-05-21 Goldberg Murray A (SVP Finance and Admin CFO and) Option Ex 4,023 18.56 74,666
2013-05-20 Goldberg Murray A (SVP Finance and Admin CFO and) Option Ex 147,967 22.82 3,376,606
2013-05-17 Brown Michael S (Director) Sale 5,000 269.60 1,348,000
2013-05-15 Brown Michael S (Director) Sale 10,000 278.28 2,782,799
2013-05-15 Brown Michael S (Director) Option Ex 15,000 24.41 366,150
2013-05-14 Aberman Michael S (VP Strategy and Investor Relat) Sale 5,529 280.07 1,548,507
2013-05-13 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 12,500 24.00 300,000
2013-05-13 Stahl Neil (SVP Research and Development S) Sale 23,038 276.92 6,379,567
2013-05-10 Stahl Neil (SVP Research and Development S) Option Ex 55,438 21.92 1,215,200
2013-05-10 Sing George L (Director) Sale 5,000 270.00 1,350,000
2013-05-10 Sing George L (Director) Option Ex 5,000 15.01 75,050
2013-05-08 Terifay Robert J (SVP Commercial) Sale 8,231 261.45 2,152,019
2013-05-07 Van Plew Daniel P (SVP & General Mgr Industrial O) Sale 13,725 261.53 3,589,499
2013-05-07 Terifay Robert J (SVP Commercial) Option Ex 16,923 16.80 284,306
2013-05-07 Yancopoulos George (President Regeneron Laboratori) Sale 100,000 262.88 26,288,000
2013-05-06 Aberman Michael S (VP Strategy and Investor Relat) Sale 8,334 256.88 2,140,796
2013-05-06 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 8,334 24.00 200,016
2013-05-06 Tessier-lavigne Marc (Director) Sale 13,334 262.11 3,494,934
2013-05-06 Tessier-lavigne Marc (Director) Option Ex 13,334 56.08 747,730
2013-05-06 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 32,950 16.80 553,560
2013-05-06 Yancopoulos George (President Regeneron Laboratori) Option Ex 192,308 13.00 2,500,004
2013-05-06 Gilman Alfred G (Director) Sale 30,000 262.57 7,877,160
2013-05-06 Gilman Alfred G (Director) Option Ex 30,000 21.77 652,950
2013-05-06 Shooter Eric M (Director) Sale 30,000 260.74 7,822,320
2013-05-06 Shooter Eric M (Director) Option Ex 20,000 43.46 869,260
2013-05-06 Vagelos P Roy (Chairman of the Board) Sale 13,482 263.67 3,554,798
2013-05-02 Mccorkle Douglas S (VP Controller & Asst Treasurer) Sale 2,213 244.40 540,859
2013-05-01 Mccorkle Douglas S (VP Controller & Asst Treasurer) Option Ex 5,875 52.03 305,676
2013-05-01 Schleifer Leonard S (President & CEO) Sale 100,000 238.72 23,872,300
2013-04-12 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 3,129 210.31 658,047
2013-04-11 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 5,875 30.63 179,951
2013-04-01 Goldstein Joseph L (Director) Sale 5,000 180.00 900,000
2013-04-01 Goldstein Joseph L (Director) Option Ex 5,000 24.41 122,050
2013-03-21 Brown Michael S (Director) Sale 15,000 173.34 2,600,100
2013-03-21 Brown Michael S (Director) Option Ex 15,000 18.61 279,150
2013-03-19 Schleifer Leonard S (President & CEO) Sale 3,655 175.02 639,698
2013-03-13 Schleifer Leonard S (President & CEO) Sale 4,662 175.01 815,896
2013-03-07 Schleifer Leonard S (President & CEO) Sale 3,534 175.13 618,909
2013-03-06 Schleifer Leonard S (President & CEO) Sale 69,003 175.69 12,123,137
2013-03-05 Schleifer Leonard S (President & CEO) Sale 19,146 175.21 3,354,570
2013-02-26 Shooter Eric M (Director) Sale 10,000 160.00 1,600,000
2013-01-16 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 7,878 172.48 1,358,765
2013-01-09 Powchik Peter (SVP Clin Devel & Reg Affairs) Option Ex 5,752 19.02 109,431
2013-01-09 Goldstein Joseph L (Director) Sale 5,000 185.00 925,000
2013-01-09 Goldstein Joseph L (Director) Option Ex 5,000 57.11 285,550
2013-01-04 Goldstein Joseph L (Director) Sale 5,000 180.86 904,300
2013-01-04 Goldstein Joseph L (Director) Option Ex 5,000 33.42 167,100
2013-01-03 Powchik Peter (SVP Clin Devel & Reg Affairs) Sale 13,586 181.93 2,471,741
2013-01-02 Powchik Peter (SVP Clin Devel & Reg Affairs) Option Ex 30,000 21.25 637,500
2012-12-20 Van Plew Daniel P (SVP & Gen Mgr IOPS) Option Ex 2,050 16.80 34,440
2012-12-20 Powchik Peter (SVP Clin Devel & Reg Affairs) Sale 6,623 170.78 1,131,042
2012-12-19 Mccorkle Douglas S (VP Controller & Asst Treasurer) Sale 1,841 177.02 325,890
2012-12-19 Powchik Peter (SVP Clin Devel & Reg Affairs) Sale 10,356 179.60 1,859,937
2012-12-19 Yancopoulos George (EVP CSO Pres Regen Res Labs) Option Ex 50,846 15.53 789,536
2012-12-18 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 1,200 24.00 28,800
2012-12-18 Mccorkle Douglas S (VP Controller & Asst Treasurer) Sale 752 178.95 134,568
2012-12-18 Mccorkle Douglas S (VP Controller & Asst Treasurer) Option Ex 4,625 21.25 98,281
2012-12-18 Terifay Robert J (SVP Commercial) Option Ex 5,952 16.80 99,993
2012-12-18 Powchik Peter (SVP Clin Devel & Reg Affairs) Option Ex 38,248 34.64 1,324,795
2012-12-17 Mccorkle Douglas S (VP Controller & Asst Treasurer) Sale 1,000 178.82 178,820
2012-12-17 Mccorkle Douglas S (VP Controller & Asst Treasurer) Option Ex 5,000 16.80 84,000
2012-12-17 Yancopoulos George (EVP CSO Pres Regen Res Labs) Option Ex 10,369 109.29 1,133,228
2012-12-17 Stahl Neil (SVP Res and Devel Sciences) Option Ex 5,952 16.80 99,993
2012-12-17 Goldberg Murray A (SVP Fin & Admin CFO Asst Secy) Option Ex 1,850 20.32 37,592
2012-12-11 Aberman Michael S (VP Strategy and Investor Relat) Sale 3,368 185.01 623,130
2012-12-10 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 7,500 30.63 229,725
2012-11-30 Aberman Michael S (VP Strategy and Investor Relat) Sale 3,904 182.37 711,956
2012-11-30 Stahl Neil (SVP Res and Devel Sciences) Sale 17,182 181.01 3,110,113
2012-11-30 Stahl Neil (SVP Res and Devel Sciences) Option Ex 9,483 21.12 200,280
2012-11-30 Roberts William (VP Regulat Dev & Med Safety) Sale 11,500 181.51 2,087,353
2012-11-29 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 8,334 24.00 200,016
2012-11-29 Sing George L (Director) Sale 5,000 185.00 925,000
2012-11-29 Vagelos P Roy (Chairman of the Board) Sale 78,630 178.52 14,037,342
2012-11-28 Vagelos P Roy (Chairman of the Board) Sale 7,004 175.03 1,225,910
2012-11-27 Vagelos P Roy (Chairman of the Board) Sale 36,246 175.69 6,367,878
2012-11-26 Baker Charles A (Director) Sale 15,000 173.47 2,601,990
2012-11-26 Baker Charles A (Director) Option Ex 15,000 9.17 137,550
2012-11-26 Vagelos P Roy (Chairman of the Board) Sale 28,507 175.12 4,992,145
2012-11-23 Terifay Robert J (SVP Commercial) Sale 9,745 174.44 1,699,917
2012-11-23 Vagelos P Roy (Chairman of the Board) Option Ex 312,500 19.43 6,071,875
2012-11-21 Terifay Robert J (SVP Commercial) Option Ex 20,000 16.80 336,000
2012-11-21 Stahl Neil (SVP Res and Devel Sciences) Sale 24,357 174.59 4,252,415
2012-11-20 Stahl Neil (SVP Res and Devel Sciences) Option Ex 54,500 16.80 915,600
2012-11-19 Vagelos P Roy (Chairman of the Board) Sale 32,500 160.82 5,226,812
2012-11-16 Van Plew Daniel P (SVP & General Mgr Industrial O) Sale 18,741 155.66 2,917,280
2012-11-16 Sing George L (Director) Sale 5,000 152.00 760,000
2012-11-16 Schleifer Leonard S (President & CEO) Option Ex 43,757 111.01 4,857,464
2012-11-14 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 3,156 148.49 468,643
2012-11-14 Brown Michael S (Director) Sale 7,000 147.03 1,029,210
2012-11-14 Brown Michael S (Director) Option Ex 7,000 23.84 166,880
2012-11-13 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 6,537 146.45 957,356
2012-11-13 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 8,176 37.13 303,574
2012-11-13 Sing George L (Director) Sale 5,000 148.00 740,000
2012-11-08 Powchik Peter (SVP Clinical Development & Reg) Sale 15,144 138.82 2,102,290
2012-11-01 Ryan Arthur F (Director) Sale 10,000 145.57 1,455,700
2012-10-26 Brown Michael S (Director) Sale 3,000 154.69 464,070
2012-10-26 Brown Michael S (Director) Option Ex 3,000 23.84 71,520
2012-10-25 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 30,000 21.92 657,600
2012-10-25 Brown Michael S (Director) Sale 2,000 155.34 310,680
2012-10-25 Brown Michael S (Director) Option Ex 2,000 23.84 47,680
2012-09-19 Powchik Peter (SVP Clinical Development & Reg) Sale 7,177 147.35 1,057,530
2012-09-18 Powchik Peter (SVP Clinical Development & Reg) Option Ex 15,000 16.80 252,000
2012-09-06 Baker Charles A (Director) Sale 13,714 150.00 2,057,100
2012-09-06 Baker Charles A (Director) Option Ex 13,714 15.01 205,847
2012-09-05 Baker Charles A (Director) Sale 1,286 150.00 192,900
2012-09-05 Baker Charles A (Director) Option Ex 1,286 15.01 19,302

Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals Inc (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.